The elevated risk of severe cardiovascular events in patients with myocardial infarction with ST segment elevation (STEMI) with high PCSK9 levels and DM may be due to the substantial association between PCSK9 and indicators of inflammation and platelet activation. This evidence concerns the gene PCSK9 and myocardial infarction.